OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · IEX Real-Time Price · USD
6.14
0.00 (0.00%)
At close: Mar 27, 2024, 12:00 AM
6.28
+0.14 (2.28%)
Pre-market: Mar 28, 2024, 6:54 AM EDT
OraSure Technologies Market Cap
OraSure Technologies has a market cap or net worth of $453.11 million as of March 28, 2024. Its market cap has increased by 2.26% in one year.
Market Cap
453.11M
Enterprise Value
176.21M
1-Year Change
2.26%
Ranking
Category
Stock Price
$6.14
Market Cap Chart
Since December 1, 1998, OraSure Technologies's market cap has increased from $72.90M to $453.11M, an increase of 521.55%. That is a compound annual growth rate of 7.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 453.10M | 0.98% |
Mar 26, 2024 | 448.70M | -2.24% |
Mar 25, 2024 | 459.00M | -1.59% |
Mar 22, 2024 | 466.40M | -0.32% |
Mar 21, 2024 | 467.90M | -2.76% |
Mar 20, 2024 | 481.20M | -3.10% |
Mar 19, 2024 | 496.60M | -1.04% |
Mar 18, 2024 | 501.80M | 2.26% |
Mar 15, 2024 | 490.70M | -3.35% |
Mar 14, 2024 | 507.70M | -2.14% |
Mar 13, 2024 | 518.80M | -0.42% |
Mar 12, 2024 | 521.00M | 2.18% |
Mar 11, 2024 | 509.90M | -4.03% |
Mar 8, 2024 | 531.30M | -0.82% |
Mar 7, 2024 | 535.70M | 4.59% |
Mar 6, 2024 | 512.20M | -0.43% |
Mar 5, 2024 | 514.40M | 1.60% |
Mar 4, 2024 | 506.30M | -5.22% |
Mar 1, 2024 | 534.20M | 1.04% |
Feb 29, 2024 | 528.70M | -6.92% |
Feb 28, 2024 | 568.00M | 9.95% |
Feb 27, 2024 | 516.60M | 0.29% |
Feb 26, 2024 | 515.10M | 0.70% |
Feb 23, 2024 | 511.50M | 3.73% |
Feb 22, 2024 | 493.10M | -2.61% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ventyx Biosciences | 471.86M |
Pulse Biosciences | 470.39M |
MaxCyte | 469.73M |
KalVista Pharmaceuticals | 469.56M |
biote | 469.55M |
Akebia Therapeutics | 466.27M |
Renovaro Biosciences | 464.05M |
Entrada Therapeutics | 461.01M |